新地(00016.HK)向平安人壽出售西九高鐵站上蓋25%權益 涉資93.9億元
新鴻基地產(00016.HK)公布,於4月29日集團訂立出售協議,出售VIVID SYNERGY LIMITED的25%權益予平安人壽全資附屬,購買價為93.94億元,另加若干償付購買價的融資成本及於該土地上興建的項目的辦公大廈部分的項目成本。
新地於去年11月尾以422.32億元投得西九高鐵站上蓋商業地,而信明乃該土地兩名註冊擁有人之一,成交前新地擁目標公司75%權益,而目標公司則擁有限於發展及營運將在該土地上興建及將由信明擁有的辦公大廈,並實際地享有該辦公大廈之所有經濟權利及利益,以及實際上承擔其一切責任及債務。
另外,公司已獲買方通知,買方亦已分別地與Somerpath就購入目標公司5%權益進行磋商,買方根據出售協議的相同基準向Somerpath支付的購買價為18.79億元加償付購買價融資成本,而該購買將於成交日完成。
交易完成後,目標公司將由新地、買方及Somerpath分別以50%、30%及20%的比例擁有,並將不再為新地的附屬公司。公司已獲買方通知,此乃平安人壽在香港投資開發平安集團香港總部大樓之項目。(el/a) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.